1. Evaluation of a near-patient SARS-CoV-2 novel rapid diagnostic platform
- Author
-
Johannes C. Botha, Karen Zafilaza, Cathia Soulie, Nicolas Yin, Moira Spyer, Sofia Balaska, Stella Chatziioannidou, Vaia Tsiakalou, George Papadakis, Lemonia Skoura, Alexandros Zafiropoulos, George Sourvinos, Olivier Vandenberg, Anne-Geneviève Marcelin, Electra Gizeli, and Eleni Nastouli
- Subjects
SARS-CoV-2 ,colorimetric LAMP ,near-patient ,point-of-care ,respiratory virus ,diagnostics ,Microbiology ,QR1-502 - Abstract
ABSTRACT The goal of this study is to test a novel device and methodology based on the “Pebble” platform and real-time quantitative colorimetric loop-mediated isothermal amplification (qcLAMP) during SARS-CoV-2 detection using crude samples and extracted RNA. The new method employs an inexpensive lightweight device aimed toward rapid point-of-care testing. An extensive evaluation was performed consisting of 1,693 clinical samples across five independent clinical testing centers. Positive colorimetric results were observed within 20 minutes of testing. At a 20-minute time-to-positive cut-off, the specificity is 98.5% with a diagnostic accuracy of 91.9%, compared to qPCR assays. Our findings indicate that the SARS-CoV-2 qcLAMP diagnostic assay in conjunction with the Pebble device is ideal for point-of-care/near-patient testing.IMPORTANCEHere, we describe our analyses and validation of a novel real-time quantitative colorimetric loop-mediated isothermal amplification (qcLAMP) device, available under the name “Pebble” and associated SARS-CoV-2 diagnostic qcLAMP assay for clinical diagnostic use. The analyses were performed in five independent testing sites across Europe using clinical samples from the associated clinical sites and support the use of “pebble” and associated kit in the diagnostic environment.
- Published
- 2024
- Full Text
- View/download PDF